Isonicotinylation is a histone mark induced by the anti-tuberculosis first-line drug isoniazid
Isoniazid (INH) is an anti-tuberculosis drug; however the underlying cause of its various side effects are not understood. Here the authors identified lysine isonicotinylation as a histone modification on chromatin that is metabolically regulated by INH and its metabolites.
Guardado en:
Autores principales: | Yuhan Jiang, Yixiao Li, Cheng Liu, Lei Zhang, Danyu Lv, Yejing Weng, Zhongyi Cheng, Xiangmei Chen, Jun Zhan, Hongquan Zhang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a75ea7e77a4d4edc993060b25acbbf6e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Drug Resistance in Mycobacterium Tuberculosis Isolates to Isoniazid and Rifampin
por: M Pourhajibagher, et al.
Publicado: (2012) -
Association between 9-month isoniazid prophylaxis of latent tuberculosis and severe hepatitis in patients treated with TNF inhibitors
por: Edward Chia-Cheng Lai, et al.
Publicado: (2021) -
Contribution of efflux to the emergence of isoniazid and multidrug resistance in Mycobacterium tuberculosis.
por: Diana Machado, et al.
Publicado: (2012) -
The clinical outcomes of oldest old patients with tuberculosis treated by regimens containing rifampicin, isoniazid, and pyrazinamide
por: Lin HS, et al.
Publicado: (2016) -
Lysine benzoylation is a histone mark regulated by SIRT2
por: He Huang, et al.
Publicado: (2018)